Form 4 for AMD Advanced Micro Devices
Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0000002488-21-000201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-09 | 2021-12-07 | AMD | Su Lisa T | Pres, CEO, Dir | S - Sale+OE | $143.72 | -125.0K | 2.27M | -5% | -$17.96M |
| D | 2021-12-09 | 2021-12-07 | AMD | Su Lisa T | Pres, CEO, Dir | M - OptEx | $2.92 | +125.0K | 2.28M | +6% | +$365.0K |
| D | 2021-12-09 | 2021-12-07 | AMD | Su Lisa T | Pres, CEO, Dir | M - OptEx | $0.00 | -125.0K | 753.5K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-07 | S | D | 20,803 | $142.79 | 2,245,324 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F4) Transaction executed in multiple trades at prices ranging from $142.19 to $143.16 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-12-07 | S | D | 11,980 | $145.43 | 2,158,150 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F7) Transaction executed in multiple trades at prices ranging from $145.19 to $145.74 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-12-07 | S | D | 38,275 | $144.56 | 2,170,130 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F6) Transaction executed in multiple trades at prices ranging from $144.19 to $145.18 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2021-12-07 | S | D | 36,919 | $143.74 | 2,208,405 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F5) Transaction executed in multiple trades at prices ranging from $143.19 to $144.18 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2021-12-07 | M | A | 125,000 | $2.92 | 2,283,150 | D | — | — | (F1) The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. |
| 6 | Common | Common Stock | 2021-12-07 | S | D | 17,023 | $141.70 | 2,266,127 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F3) Transaction executed in multiple trades at prices ranging from $141.19 to $142.18 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option Grant | 2021-12-07 | M | D | 125,000 | $0.00 | 753,457 | D | $2.92 · — to 2022-12-26 | 125,000 Common Stock | (F8) This option vested 33 1/3% on December 26, 2016 and 8 1/3% per quarter over the subsequent eight quarters. |